Recent Updates
Recently added Catalysts
ALLO

Allogene Therapeutics Presents Preclinical Data Demonstrating the Potential of AlloCAR T Therapy in Renal Cell Carcinoma (RCC) at the 2019 AACR Annual Meeting

Monday, April 1, 2019 1 min read
Key Takeaway: Allogene Therapeutics Presents Preclinical Data Demonstrating the Potential of AlloCAR T Therapy in Renal Cell Carcinoma (RCC) at the 2019 AACR Annual Meeting

Full Press Release Details

Allogene Therapeutics Presents Preclinical Data Demonstrating the Potential of AlloCAR T Therapy in Renal Cell Carcinoma (RCC) at the 2019 AACR Annual Meeting.
Tags: ALLO Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Apr 1, 2019